Table 4 Estimated prevalence of ACEI-AE in the US, German and French population supported by population-based estimates of the use of ACEI

Adult population (18+):

235,153,929[35]

67,085,343 [36]

47,911,356 [37]

High blood pressure (18+):

29.1% [19]

68,429,793

31.6% [38]

21,198,968

31.0% [22]

14,852,520

Treated for HBP:

76.4% [19]

52,280,362

71.8% [38]

15,220,859

50.3% [22]

7,470,818

ACEI-use among HBP treated:

33.3% [20]

17,409,361

45.0% [21]

6,849,387

26.7% [39]

1,994,708

 (low – 0.12%):

20,891

8219

2394

 (high – 0.30%):

52,228

20,548

5984

Population (all ages):

309,349,689[35]

80,219,695 [36]

61,538,322 [37]

 low

0.7

1.0

0.4

 high

1.7

2.6

1.0